The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

There are many claims about the benefits of microdosing weight-loss drugs, from anti-inflammatory effects to extending ...

Odds for desensitization and remission fell as patients missed consecutive doses of peanut oral immunotherapy, according to a ...

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

Imunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

In this trial, the efficacy and safety of the therapy were evaluated against a sham control in treatment-naïve SMA Type 2 ...